Samuel Ruder

Also affiliated with Cornell University, New York Hospital Queens, Presbyterian Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis”.

Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis

Human Pathology(2022)10.1016/j.humpath.2022.01.009

N/A

0.489DataRank · unranked

25 citations

Yan Gao, Yi Ding, Ping Bu, Brian J. Miles, Angelo De Marzo +25 more

PSMA-targeted actinium-225 therapy in metastatic castration-resistant prostate cancer (mCRPC): Baseline and follow-up PSMA PET parameters associated with outcomes.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5070

N/A

0.104DataRank · unranked

1 citations

Charlene Thomas, Gabriel Raab, Aaron N. Holmes, Tobechukwu Okobi, Andres Ricaurte‐Fajardo +11 more